At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 220 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
In plain English
This study collects information from people treated for an abdominal aortic aneurysm (AAA) — a swollen, weakened area in the body's main artery in the tummy — using two W.L. Gore & Associates devices: the GORE® EXCLUDER® Conformable AAA Endoprosthesis or the Iliac Branch Endoprosthesis. These devices are placed inside the artery to treat the aneurysm. The study is run by the device maker, W.L. Gore & Associates.
Who can take part
- Adults aged 18 or over
- The patient (or their legal representative) gives written permission or consent
- The patient has been treated, or is due to be treated, with one of the study devices
Who may not be able to
- People unlikely to attend the standard follow-up check-ups set by their hospital
- People excluded for reasons set by local law
- People already in, or planning to join, another drug or device study within 12 months — and nobody can be in more than one part of the Together Registry at the same time
What taking part involves
- • Not stated — ask the trial team
- • The study records information about treatment with the two named Gore devices
Time commitment: Taking part involves being available for standard follow-up visits as set by your hospital; the number of visits and total study length are not stated — ask the trial team.
Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 2,000
- Started
- 2024-05-07
- Last checked
- 2026-02
Plain English Summary
What is this study?
- • Testing a new treatment for aaa - abdominal aortic aneurysm
- • Clinical study - 2,000 participants
- • A prospective, observational post-market registry collecting outcomes through a 10-year post procedure follow-up for patients treated with the GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC Device) or the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE Device) as a part of routine clinical practice
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with aaa - abdominal aortic aneurysm
Where?
- • Leicester - University Hospitals of Leicester NHS Trust
- • Liverpool - Countess of Chester Hospital NHS Foundation Trust
- • Liverpool - Countess of Chester Hospital NHS Foundation Trust
- • London - Imperial College Healthcare NHS Trust, St. Mary's Hospital
- • +2 more UK sites
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
A prospective, observational post-market registry collecting outcomes through a 10-year post procedure follow-up for patients treated with the GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC Device) or the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE Device) as a part of routine clinical practice.
More detail
The purpose of the Gore Together Aortic Registry is to collect real-world data (RWD) for Gore aortic endovascular devices. Due to the nature of the program, patient selection, diagnostic imaging, and treatment interventions will be determined by physicians based on standard clinical practice. Therefore, the Sponsor will not be outlining requirements that would influence healthcare decisions. Participants will be asked to return for regular scheduled visits as requested by their surgeon. Patients will report any issues they may have regarding the device or surgery to their surgeon/doctor.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and...
- ✓Patient has been or is intended to be treated with an eligible registry device
- ✓Patient is age ≥ 18 years at time of agreement to take part signature.
Who cannot take part
- ✗Patient who is, at the time of consent, unlikely to be available for the usual treatment (SOC) follow-up visits as...
- ✗Patient with exclusion criteria required by local law.
See the full criteria
Where Is This Study? (6 UK sites)
University Hospitals of Leicester NHS Trust
Leicester, United Kingdom
Countess of Chester Hospital NHS Foundation Trust
Liverpool, United Kingdom
Countess of Chester Hospital NHS Foundation Trust
Liverpool, United Kingdom
Imperial College Healthcare NHS Trust, St. Mary's Hospital
London, United Kingdom
St Thomas Hospital - Guys and St. Thomas' NHS
London, United Kingdom
St Thomas Hospital - Guys and St. Thomas' NHS
London, United Kingdom
How to Get in Touch
Karen Martin
Sponsor contactCONTACT
A. Lekuti
Sponsor contactCONTACT